Prostaglandin receptor, a sub-family of cell surface seven-transmembrane receptors, are the G-protein-coupled receptors.Ten distinct prostaglandin receptors on different cell types are currently known. G-protein-coupled receptors are a subclass of cell surface seven-transmembrane receptors that prostaglandins bind to. The following are the names of these receptors: FP-FP, IP1-2-IP1, IP2 receptors, TP-TP receptor, EP1-4-EP1, EP2, EP3, and EP4 receptors. A class of lipid molecules known as prostaglandins, which are produced enzymatically from fatty acids and resemble hormones, play vital roles in the bodies of animals. Ten distinct prostaglandin receptors on different cell types are currently known.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V111874 | IP receptor antagonist 1 | CAY10449 is a type I prostaglandin receptor antagonist. | |
|
V114425 | Pimilprost | 139403-31-9 | Pimiprost (SM 10902) is a prostaglandin I1 analog. |
|
V114380 | Nafagrel hydrochloride | 97901-22-9 | Naphthogrel hydrochloride is a thromboxane A2 synthase inhibitor. |
|
V109041 | CT-133 | 2417155-47-4 | CT-133 is a selective and potent CRTH2 receptor antagonist with a Ki value of 2.2 nM and a Ki value greater than 3800 nM for the DP1 receptor. |
|
V109013 | rel-Latanoprost acid | 2699713-95-4 | rel-latanoprostonic acid is a relative configuration of latanoprostonic acid. |
|
V109028 | EP2 receptor agonist 2 | 1807780-00-2 | EP2 receptor agonist 2 (compound 18a) is a potent and selective G protein-biased EP2 receptor agonist (EC50 for hEP2 G protein = 13 nM, EC50 for hEP2β repressor protein > 10000 nM). |
|
V115508 | NP-184 | 78706-11-3 | NP-184 is a novel oral active antithrombotic drug. |
|
V117120 | KC-764 | 94457-09-7 | KC-764 is an orally effective reversible cyclooxygenase inhibitor with relative selectivity for platelet cyclooxygenase. |
|
V112375 | TP receptor antagonist-3 | 165537-72-4 | TP receptor antagonist-3 (compound 51280) is a potent thromboxane A2 prostaglandin (TP) receptor antagonist with an IC50 value of 15.7 nM for human TP. |
|
V112300 | Picotamide monohydrate | 80530-63-8 | Pyrcoamide monohydrate is a complex inhibitor of thromboxane A2 (TxA2) synthase and receptor, and also has antiplatelet activity. |
|
V114621 | Nileprost | 71097-83-1 | Nileprost is a prostacyclin analogue and a mixed PGI2/PGE2 agonist. |
|
V114577 | Flunoprost | 86348-98-3 | Flunoprost is a stable prostaglandin E analogue. |
|
V114667 | CV-6504 | 117574-40-0 | CV-6504 is a dual inhibitor of TXA2 synthase and 5-lipoxygenase. |
|
V114676 | FCE 20700 | 89648-76-0 | FCE 20700 is an orally effective PGE2 analogue. |
|
V116409 | CCI17464 | 325780-75-4 | CCI17464 is a selective, orally effective partial EP4 agonist with a pKi value of 7.1. |
|
V116468 | TGI-15 | 3073601-32-5 | TGI-15 is a highly selective prostaglandin F receptor antagonist. |
|
V115056 | KT2-962 | 129648-96-0 | KT2-962 is a thromboxane A2 (TXA2) receptor antagonist and a potent hydroxyl radical scavenger (IC50 = 500 nM). |
|
V116612 | EP4 receptor antagonist 8 | 3068255-86-4 | EP4 receptor antagonist 8 is an orally effective EP4 receptor antagonist (human EP4 IC50 = 6.40 nM). |
|
V118275 | IP receptor agonist 1 | 3029113-61-6 | IP receptor agonist 1 (compound 6c-14S) is an orally effective type I prostaglandin receptor agonist with an IC50 value of 0.15 μM. |
|
V114185 | Sepetaprost | 1262873-06-2 | Seperprost (ONO-9054) is a dual agonist of prostaglandin E3 receptor and prostaglandin F receptor. |